← Back to headlines
Bombay High Court Criticizes Drug Regulator Over Cipla License Cancellation
The Bombay High Court has reprimanded India's drug regulatory authority for its handling of the license cancellation case involving pharmaceutical company Cipla.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
